Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)

ClinicalTrials.gov ID: NCT01573351

Public ClinicalTrials.gov record NCT01573351. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 3:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-Label Study With Asunaprevir and Daclatasvir Plus Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) (P/R) (QUAD) for Subjects Who Are Null or Partial Responders to Peginterferon Alfa 2a or 2b Plus Ribavirin With Chronic Hepatitis C Genotypes 1 or 4 Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess efficacy, as determined by the proportion of subjects with Sustained Virologic Response at Post-Treatment Week 12 (SVR12), defined as Hepatitis C virus (HCV) Ribonucleic acid (RNA) \< Limit of quantitation (LOQ) at post-treatment Week 12.

Study identification

NCT ID
NCT01573351
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
398 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2012
Primary completion
Aug 31, 2013
Completion
Nov 30, 2013
Last update posted
Oct 8, 2015

2012 – 2013

United States locations

U.S. sites
20
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
Alabama Liver & Digestive Specialists (Alds) Montgomery Alabama 36116
Scripps Clinic La Jolla California 92037
Scpmg/ Kaiser Permanente Los Angeles Medical Center Los Angeles California 90027
University Of Colorado Denver And Hospital Aurora Colorado 80045
South Denver Gastroenterology, Pc Englewood Colorado 80113
Mayo Clinic Jacksonville Florida 32224
University Of Miami Schiff Center For Liver Diseases Miami Florida 33136
University Of Chicago Medical Center Chicago Illinois 60637-1432
North Shore University Hospital Manhasset New York 11030
University Of North Carolina At Chapel Hill School Of Med Chapel Hill North Carolina 27599-7584
University Of Cincinnati Cincinnati Ohio 45267
Options Health Research, Llc Tulsa Oklahoma 74104
Oregon Health & Science University Portland Oregon 97239
University Of Pennsylvania Philadelphia Pennsylvania 19104
Thomas Jefferson University Philadelphia Pennsylvania 19107
Gastro One Germantown Tennessee 38138
Baylor College Of Medicine Houston Texas 77030
Texas Liver Institute San Antonio Texas 78215
Mcguire Dvamc Richmond Virginia 23249
Dean Clinic Madison Wisconsin 53715

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01573351, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2015 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01573351 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →